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Introduction: Critically ill patients with sepsis are prone to develop cardiac dysrhythmias, most commonly atrial
fibrillation (AF). Systemic inflammation, circulating stress hormones, autonomic dysfunction, and volume shifts are
all possible triggers for AF in this setting. We conducted a systematic review to describe the incidence, risk factors
and outcomes of new-onset AF in patients with sepsis.
Methods: MEDLINE, EMBASE and Web Of Science were searched for studies reporting the incidence of new-onset
AF, atrial flutter or supraventricular tachycardia in patients with sepsis admitted to an intensive care unit, excluding
studies that primarily focused on postcardiotomy patients. Studies were assessed for methodological quality using
the GRADE system. Risk factors were considered to have a high level of evidence if they were reported in ≥2
studies using multivariable analyses at a P value <0.05. Subsequently, the strength of association was classified as
strong, moderate or weak, based on the reported odds ratios.
Results: Eleven studies were included. Overall quality was low to moderate. The weighted mean incidence of
new-onset AF was 8% (range 0 to 14%), 10% (4 to 23%) and 23% (6 to 46%) in critically ill patients with sepsis,
severe sepsis and septic shock, respectively. Independent risk factors with a high level of evidence included advanced
age (weak strength of association), white race (moderate association), presence of a respiratory tract infection (weak
association), organ failure (moderate association), and pulmonary artery catheter use (moderate association). Protective
factors were a history of diabetes mellitus (weak association) and the presence of a urinary tract infection (weak
association). New-onset AF was associated with increased short-term mortality in five studies (crude relative effect
estimates ranging from 1.96 to 3.32; adjusted effects 1.07 to 3.28). Three studies reported a significantly increased
length of stay in the ICU (weighted mean difference 9 days, range 5 to 13 days), whereas an increased risk of ischemic
stroke was reported in the single study that looked at this outcome.
Conclusions: New-onset AF is a common consequence of sepsis and is independently associated with poor outcome.
Early risk stratification of patients may allow for pharmacological interventions to prevent this complication.Introduction
New-onset atrial fibrillation (AF) is a common compli-
cation of critical illness, with a reported incidence that
varies from 4 to 9% in general intensive care unit (ICU)
patients to 32 to 50% in postcardiotomy patients [1-3].
Furthermore, new-onset AF predicts mortality in pa-
tients who are hospitalized for heart failure as well as
various other critical conditions, although it is possible* Correspondence: o.l.cremer@umcutrecht.nl
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unless otherwise stated.that AF in these cases is primarily a marker of disease
severity rather than a direct cause of death [4-6]. None-
theless, the development of AF is associated with a
sudden reduction in cardiac output and rise in filling
pressures and it is, therefore, possible that increased
mortality is due to the adverse consequences of AF on car-
diac function [4]. In addition, chronic AF is associated
with thromboembolic complications, and it is plausible
that some of these risks also affect critically ill patients
with an acute episode of AF [7].
Although cardiac arrhythmias in the general ICU popu-
lation have been described since the early 1990s [5,8],. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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with neither exclusion of subjects who had a cardiac rea-
son for admission nor those with a known history of
chronic or paroxysmal AF. As a consequence, the true in-
cidence and prognosis of new-onset AF in patients pre-
senting with sepsis remains unknown.
Sepsis is characterized by a systemic release of proin-
flammatory cytokines, high levels of circulating stress
hormones, autonomic dysfunction, and may be compli-
cated by organ dysfunction [9,10]. In addition, intravas-
cular volume shifts and cardiovascular compromise will
frequently lead to hypotension and elevated lactate levels
[11]. All of these features of sepsis are possible triggers
for the development of AF [12].
If AF causes poor outcome it might be desirable to
start antiarrhythmic prophylaxis in critically ill patients
with sepsis in an attempt to prevent this complication.
Current guidelines advise the use of beta blockers or
amiodarone to prevent postoperative AF in patients fol-
lowing cardiac surgery [13] and it is conceivable that a
preemptive strategy could also be effective in patients
with (severe) sepsis. Identification of patients at highest
risk for AF is therefore important. We aimed to gain
better understanding of the incidence, risk factors and
outcomes of new-onset AF in critically ill patients with
sepsis.
Methods
Data sources and search strategy
We searched the literature from 1966 through 2013
using MEDLINE, EMBASE and Web of Science. In our
query we used compound search strings for both the
determinant (atrial fibrillation) and domain (sepsis) (see
Additional file 1 of the online supplemental digital con-
tent for full specification of our search query). Only
articles published in English, Dutch, French or German
were considered for this review. We screened titles and
abstracts of identified articles and included all studies
describing the incidence, risk factors or outcome of
new-onset AF, atrial flutter or other supraventricular
tachycardia occurring during ICU stay in adult patients
with sepsis, severe sepsis or septic shock. Patients with a
supraventricular tachycardia that was not further speci-
fied or of unknown origin were included because we ex-
pected a high percentage of AF among these patients.
Furthermore, we also included reports that primarily fo-
cused on patients with severe sepsis and septic shock
but that were not specifically restricted to the ICU set-
ting, because we expected a high proportion of critically
ill patients to be represented in these studies. We ex-
cluded reports that primarily included patients following
cardiotomy, that contained no original data, that were
published only in abstract form, or that provided no
clear definition of the patients or the arrhythmia beingstudied. Institutional Review Board approval was not
sought since our study did not involve human research.
Quality assessment
Studies that met the inclusion criteria were evaluated for
their methodological quality using the Grading of Recom-
mendations Assessment, Development and Evaluation
(GRADE) guidelines [14]. The following items were
assessed: study design, sample size, domain definition, de-
terminant parameterization, risk factor parameterization
and outcome parameterization. We scored all items on a
four-point scale from low to high.
Data analysis
Abstracts were screened for inclusion by the primary au-
thor. Articles that were selected for full-text review were
assessed by both the first and second author. In case of
uncertainty about study inclusion consensus was sought
with the third author. Subsequently, data were extracted
by the primary author. Where possible, the cumulative
incidence of new-onset AF during the sepsis episode, the
odds ratios (ORs) for the relations between risk factors
and the occurrence of AF, and the OR for the relation
between AF and mortality were calculated based on the
crude data provided in the article. We calculated
weighted mean incidences across studies by summing
the reported frequencies of AF in all eligible studies and
dividing this by the total number of participants. Risk
factors were considered to have a high level of evidence
if a significant association (P <0.05) was reported in ≥2
studies using multivariable analyses; a moderate level of
evidence if a significant association was reported in a
single study using a multivariable analysis, or in ≥2 stu-
dies using univariable analyses; and a low level of evi-
dence if a significant association was reported in a single
study using a univariable analysis. The strength of associ-
ation was then classified as strong (OR <0.4 or >3.0), mod-
erate (OR 0.4 to 0.7 or 1.5 to 3.0) and weak (OR = 0.7 to
0.9 or OR = 1.1 to 1.5) [15].
Results
Based on our initial search results, 1,212 articles were
screened, of which 1,168 were rejected after review of
title and abstract. An additional 33 articles were ex-
cluded after full review, leaving 11 papers for inclusion
(Figure 1) [16-26].
Table 1 shows general characteristics of the included
studies. Only six studies used a method of prospective
data collection, whereas the others were retrospective
analyses of existing databases. The total number of in-
cluded patients with sepsis varied widely, ranging from
18 to 49,082 per study. The overall methodological qua-
lity of the studies was only low to moderate (GRADE
scores 2 and 3). See Additional file 2 of the online
Figure 1 Flowchart of study selection process.
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the individual studies. This was mostly due to a retro-
spective study design, a small sample size, a poor defi-
nition of the study domain, an uncertain diagnosis of the
determinant (that is, the occurrence of AF), and a lack
of multivariable analyses when assessing risk factors.
Two studies [24,25] did not explicitly distinguish bet-
ween patients managed in an ICU or at the ward, yet
remained in our review because the provided data sug-
gested that the vast majority of included patients were
indeed critically ill.
Table 2 shows the incidence of new-onset AF in pa-
tients with sepsis by various stages of disease progres-
sion. The weighted mean incidence of new-onset AF was
8% (range 0 to 14%), 10% (4 to 23%) and 23% (6 to 46%)
in patients with sepsis, severe sepsis and septic shock,
respectively. Not all studies reported the incidences of
new-onset AF for the various disease stages separately.
Three studies reported only a combined incidence for
patients with either sepsis or severe sepsis (mean 5%,
range 3 to 10%) [17,22,23]; one study reported an inci-
dence for patients with either severe sepsis or septic
shock (28%) [26]; and another two studies reported an
incidence for patients with sepsis of unspecified severity
(mean 28%; range 25 to 50%) [16,19]. In contrast, a
single large study that was not formally restricted to the
ICU setting only, and that used International Classifica-
tion of Diseases-Ninth Revision-Clinical Modification(ICD-9-CM) codes to detect episodes of new-onset AF,
reported an incidence of 5% in hospitalized patients with
severe sepsis and 6% in patients with septic shock. No
studies reported the number of recurrent AF episodes
per ICU admission, their duration, or their hemo-
dynamic consequences. Two studies reported the thera-
peutic interventions that were performed in response to
AF onset in patients with sepsis, including electrical car-
dioversion (31%) and the initiation of antiarrhythmic
drugs such as amiodarone (73%), digoxin (63%), bêta
blockers (51%), and other/unspecified medications for
rate-control (52%) or pharmacologically cardioversion
(12%) [20,21].
Table 3 shows the risk factors for the development of
new-onset AF in patients with sepsis that were reported
at least once at a significance level <0.05 (see Additional
file 3 of the online data supplement for a complete over-
view of all potential risk factors). Risk factors with a high
level of evidence included advanced age, white race,
presence of a respiratory tract infection, organ failure,
and use of a pulmonary artery catheter. In contrast, the
incidence of AF was reduced in patients with diabetes
mellitus and those with urinary tract infections. Conflic-
ting results were found for a history of hypertension and
chronic obstructive pulmonary disease (COPD).
Table 4 shows outcomes for patients with at least a
single episode of new-onset AF as compared to patients
with maintained sinus rhythm. All studies reporting
Table 1 Overview of included studies
Reference Setting Number of patients
with sepsis/totala
Detection method AF Outcome Methodological
qualityb
Arora et al., 2007 [16] Single center,
mixed ICU, Australia.
18/61 Prospective bedside detection +12-lead
confirmation
n/a Moderate
Christian et al., 2008 [17] Single center,
mixed ICU, USA.
274/274 Retrospective review of monitor data
from a database developed for
benchmarking
Death Moderate
Gomez et al., 2012 [18] Multicenter,
mixed ICUs, Columbia.
100/100 Prospective detection using telemetry n/a Low
Goodman et al., 2007 [19] Single center,
mixed ICU, Israel.
149/611 Prospective bedside detection +12-lead
confirmation.
n/a Moderate
Meierhenrich et al., 2010 [20] Single center,
surgical ICU, Germany.
50/629 Prospective bedside detection +12-lead
confirmation
Death Moderate
Salman et al., 2008 [21] Single center,
mixed ICU, USA.
81/81 Retrospective review of monitor data
from a hospital record database
Death Moderate
Seguin et al., 2006 [22] Single center,
trauma ICU, France.
36/293 Prospective bedside detection +12-lead
confirmation
n/a Low
Seguin et al., 2004 [23] Single center,
surgical ICU, France.
107/460 Prospective bedside detection +12-lead
confirmation
n/a Moderate
Walkey et al., 2011 [24] Multicenter, acute
care hospital, USA.
49,082/49,082 Retrospective review from an
administrative claims database using
ICD-9-CM codes for detection of AF
Death Moderate
Stroke
Walkey et al., 2013 [25]c Multicenter, Medicare
hospital, USA.
40,740/40,740d Retrospective review from an
administrative claims database using
ICD-9-CM codes for detection of AF
n/a Moderate
Wells et al., 2011 [26] Single center, medical
ICU, USA.
465/1466 Retrospective review from an
administrative database, detection of AF
using telemetry
Death Low
aWhen studies differentiate between sepsis, severe sepsis and septic shock, the number of patients with sepsis equals the number of all patients with sepsis
including patients with severe sepsis and septic shock; bsee Additional file 2 for a detailed appraisal of the individual studies; cWalkey 2013 [25] only excluded
patients after cardiothoracic surgery in a sensitivity analysis for identification of the risk factors, therefore we used this study only for the analysis of risk factors;
dthe number of patients with sepsis excluding patients with cardiothoracic surgery or endocarditis during the sepsis hospitalization. AF: atrial fibrillation;
ICD-9-CM: International Classification of Diseases-Ninth Revision-Clinical Modification; ICU: intensive care unit; n/a: not available.
Table 2 Incidence of new-onset atrial fibrillation in patients with various stages of sepsis
Reference Disease stage
Sepsis Severe sepsis Septic shock
ICU population
Arora et al., 2007 [16] [ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 9/18 (50%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -]
Christian et al., 2008 [17] 6/184 (3%) 10/90 (11%)
Gomez et al., 2012 [18] 0/10 (0%) 1/28 (4%) 4/62 (6%)
Goodman et al., 2007 [19] [ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 37/149 (25%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -]
Meierhenrich et al., 2010 [20] 23/50 (46%)
Salman et al., 2008 [21] 2/14 (14%) 3/13 (23%) 20/54 (37%)
Seguin et al., 2006 [22] 3/29 (10%) 2/7 (29%)
Seguin et al., 2004 [23] 5/84 (6%) 7/23 (30%)
Wells et al., 2011 [26] 132/465 (28%)
Mixed population
Walkey et al., 2011 [24]* 1074/20253 (5%) 1822/28829 (6%)
The numerators of the fractions in this table display the number of patients with new-onset AF, the denominators of the fractions display the total number of
patients at risk in the specific sepsis stages. Whenever the incidence of new-onset AF for the various stages of sepsis was not reported separately, the combined
incidences are shown. *This study included hospitalized patients with severe sepsis and septic shock, based on ICD-9-CM discharge codes; although most patients
had been admitted to the ICU, the study was not formally restricted to critically ill patients only (source: personal communication by the author). AF: atrial fibrillation;
ICD-9-CM: International Classification of Diseases-Ninth Revision-Clinical Modification; ICU: intensive care unit.
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Table 3 Level of evidence and strength of association of selected risk factors for new-onset atrial fibrillation in patients
with sepsis
Risk factor category Variables Level of
evidencea
Strength of associationb
Univariable analysis Multivariable analysis
Strength Referencesd Strength Referencesd
Demographics Increased age, per 10 years ●●● n/a [17,20,21,24,26] M + W + [24,25]
Male gender ●●○ M + M + M + W + [20,21,24,26] W + No [24,25]
White race ●●● S + M + M + [21,24,26] M + M + [24,25]
Comorbidities COPD ●●○ S + M + W + W + [20,21,24,26] W - [25]
Diabetes mellitus ●●● M - W - W + [21,24,26] W - W - [24,25]
Obesity ●●○ W - [24] W + [24]
Heart failure ●●○ M + M + [20,24] M + No [24,25]
Hypertension ●○○ S + W + W - [20,21,24] W - No [24,25]
Coronary artery disease ●○○ S + M + M + [20,21,26]
Myocardial infarction ●○○ W + [24]
Stroke ●●○ M + M + [21,24] M + [24]
Renal disease ●●○ W - [25]
Malignancy ●●○ W + [24] W + [25]
Source of infection Primary blood stream ●●○ W - [24] W + [24]
Respiratory tract ●●● M + [24] W + W + [24,25]
Abdominal ●●○ M + [24] M + [24]
Urinary tract ●●● W - [24] W - W - [24,25]
Skin or soft tissue ●●○ No [24] W + W - [24,25]
Pathogen Fungal ●●○ M + [24] M + [24]
Gram-positive bacteria ●●○ W + [24] W + [24]
Severity of disease Organ failurec ●●● S + M + n/a n/a [17,24,20,21] M + M + [24,25]
Electrolyte abnormality ●○○ W + [24]
Critical care interventions Pulmonary artery catheter use ●●● S + S + [17,24] M + W + [24,25]
Mechanical ventilation ●●○ S + [17] W + [24]
aLevel of evidence: high (●●●): risk factor reported in ≥2 references using multivariable analyses at a P value <0.05; Moderate (●●○): risk factor reported in 1
reference using multivariable analysis at a P value <0.05 or ≥2 references using univariable analyses at a P value <0.05; low (●○○): risk factor reported in 1
reference using univariable analysis at a P value <0.05; bstrength of association: Strong positive association (S+): OR >3; Moderate positive association (M+):
OR = 1.5 to 3.0; Weak positive association (W+): OR <1.5; Strong negative association (S-): OR <0.4; Moderate negative association (M-): OR = 0.4 to 0.7; Weak
negative association (W-): OR >0.7; No association (No): OR = 0.9-1.1 (based on [15]); cthis includes high APACHE II, APS or SOFA scores, or the presence of shock
upon ICU admission; dthe references refer to the columns showing the strength of association. APACHE II: Acute Physiological and Chronic Health Evaluation II;
APS: Acute Physiology Score; COPD: chronic obstructive pulmonary disease; ICU: intensive care unit; n/a: not available; OR: odds ratio; SOFA: Sequential Organ
Failure Assessment.
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who had developed AF during their stay. Estimated ORs
varied from 1.96 (95% confidence interval (CI) 1.26 to
3.03) to 3.32 (95% CI 1.12 to 9.84) for acute (that is,
ICU or in-hospital) mortality, and from 2.25 (95% CI
0.66 to 7.73) to 4.29 (95% CI 1.53 to 11.97) for 28-day
mortality. Only two studies reported a measure of as-
sociation that was corrected for baseline imbalances in
severity of illness, with an adjusted relative risk (RR)
1.07 (95% CI 1.04 to 1.11) for in-hospital mortality and
adjusted OR 3.28 (95% CI 1.13 to 9.57) for 28-day mor-
tality, respectively [21,24]. Three studies reported a sig-
nificantly increased length of stay for patients who had
experienced an episode of new-onset AF in the ICU(weighted mean difference 9 days, reported range 5 to
13 days) [17,20,21]. An increased risk for in-hospital ische-
mic stroke was found in a single study that reported this
outcome (adjusted OR 2.70, 95% CI 2.05 to 3.57) [24].
Discussion
The reported incidence of new-onset AF varies greatly
in critically ill patients with sepsis, but consistently rises
with progression from milder stages of the disease to
shock. Furthermore, the occurrence of even a single
episode of AF is associated with increased mortality, in-
creased length of stay and - possibly - an increased risk
of stroke in these patients, both in crude and adjusted
analyses. This suggests that new-onset AF is causally
Table 4 Outcomes of new-onset atrial fibrillation in patients with sepsis, severe sepsis or septic shock
Reference Outcome Patients with new-onset
AF (number of patients
with outcome/total)
Patients without new-onset
AF (number of patients
with outcome/total)
Crude OR P value Adjusted OR P value
Christian et al., 2008 [17] ICU mortality 11/16 (69%) 102/256 (40%) 3.32 (1.12- 9.84) 0.03
Meierhenrich et al., 2010 [20] ICU mortality 10/23 (44%) 6/27 (22%) 2.69 (0.79-9.17) 0.14
28-day mortality 9/23 (39%) 6/27 (22%) 2.25 (0.66-7.73) 0.22
Salman et al., 2008 [21] ICU mortality 12/25 (48%) 15/56 (27%) 2.52 (0.95-6.74) 0.06
In-hospital mortality 16/25 (65%) 20/56 (38%) 3.20 (1.20-8.55) 0.02
28-day mortality 18/25 (72%) 21/56 (38%) 4.29 (1.53-11.97) 0.004 3.28 (1.13-9.57)a 0.03
Walkey et al., 2011 [24] In-hospital mortality 1629/2896 (56%) 13652/36200 (38%) 2.12 (1.97-2.29) <.0001 1.07 (1.04-1.11)b,c n/a
In-hospital ischemic stroke 75/2896 (3%) 249/36200 (1%) 3.84 (2.96-4.98) <.0001 2.70 (2.05-3.57)d n/a
Wells et al., 2011 [26] ICU/in-hospital mortality 95/132 (72%) 189/333 (57%) 1.96 (1.26-3.03) 0.002
Data are expressed as absolute numbers (%) unless other specified. aAdjusted for the severity of illness at ICU admission measure by the Acute Physiology and Chronic Health Evaluation (APACHE) III predicted
mortality rate; badjusted for: age, sex, race/ethnicity, history of diabetes mellitus, hypertension, obesity, heart failure, stroke, myocardial infarction, chronic obstructive pulmonary disease, metastatic or hematologic
malignancy, number of organ failures, presence of electrolyte disturbance, source of sepsis, type of organ failure, type of pathogenic organism and use of pulmonary artery catheter; crelative risk; dadjusted for: age,
sex, race/ethnicity, history of diabetes mellitus, hypertension, obesity, heart failure, stroke, myocardial infarction, chronic obstructive pulmonary disease, metastatic or hematologic malignancy, number of organ
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sepsis.
The incidences of new-onset AF in patients with sepsis
admitted to the ICU that we found in our systematic
review are higher than the 4 to 9% occurrence rates
reported for general ICU populations, but lower than
the estimated 30 to 50% rate in postcardiotomy patients
[1-3]. Furthermore, the reported incidences in our re-
view varied widely between studies, which may be ex-
plained by random variation due to the small sample
sizes of most included studies, but also by differences in
patient populations and by misclassification (that is, not
all episodes of AF may have been correctly detected). In
fact, the domain was not clearly defined in five studies,
and some did not explicitly exclude patients who deve-
loped sepsis following cardiac surgery [18,22-24,26]. In
addition, another seven studies did not explicitly exclude
patients with a prior history of chronic or paroxysmal
AF [16,18,21-24,26]. Both of these shortcomings may
have led to an overestimation of the AF incidence due to
sepsis. Of note, a single large study did not explicitly
stipulate ICU admission as an entry requirement, yet
was included in our analyses of risk factors and out-
comes since most patients with severe sepsis or septic
shock were expected to be critically ill indeed [24]. How-
ever, given the uncertainty about domain, this study was
excluded from the calculation of pooled incidences of
new-onset AF in an ICU setting.
Misclassifications might have also occurred due to
differences in the methods used for diagnosing AF. Pro-
spective use of continuous bedside monitoring can de-
tect even short episodes of new-onset AF that may have
only limited clinical relevance, whereas retrospective
classification of AF based on available administrative da-
tabases will likely result in underreporting. Indeed, the
three retrospective studies found lower incidences than
most of the prospective studies in our review [17,21,24].
Risk factors for the development of AF in patients with
sepsis were reported in only six of the included studies
[17,20,21,24-26]. Markers of illness severity (such as the
presence of organ failures and shock) as well as several
critical care interventions were associated with an in-
creased risk of AF. These findings give support for the
general notion that AF may be triggered by high levels
of circulating proinflammatory cytokines, catecholami-
nergic stress electrolyte imbalances, and a disrupted
volume status during sepsis. In addition, known risk fac-
tors for chronic or paroxysmal AF in the general popula-
tion, such as advanced age, white race, male gender,
obesity and (ischemic) heart failure, were also associated
with the development of AF during sepsis [27,28]. How-
ever, in contrast to reported associations in the general
population, the included studies did not identify hyper-
tension, valvular heart disease or diabetes as significantrisk factors [27-29]. In fact, two studies paradoxically
reported that diabetes mellitus was associated with a
decreased risk of AF onset [24,25]. It might be that pa-
tients with diabetes mellitus who did not develop paro-
xysmal or chronic AF prior to their acute illness were
characterized by some (unknown) factors that protected
them from developing this dysrhythmia during the sepsis
event. Conflicting results were found for a history of
hypertension and COPD [20,24-26]. The authors repor-
ting an (unexpected) reduced risk of AF stated that this
finding may have been an artifact that was due to under-
reporting of chronic comorbidities in their data [24,25].
However, in that case we would not expect a protective
effect.
Outcomes of new-onset AF in patients with sepsis
were described in five studies [17,20,21,24,26]. All stu-
dies consistently reported worse outcome in patients
with new-onset AF as compared to patients with pre-
served sinus rhythm, although only two studies used
multivariate analyses to adjust for baseline imbalances
[21,24]. Even then, residual confounding in both studies
is likely since only limited numbers of covariables were
collected and time-dependent variations in the evolution
of disease severity prior to the onset of AF were ignored.
Methodologically advanced analytical approaches are ne-
cessary to demonstrate genuinely independent associa-
tions with morbidity and mortality. In the end, therefore,
it still remains somewhat elusive to what extent new-
onset AF in patients with sepsis truly impacts outcome.
However, given the consistency of the findings across
settings and biological plausibility, a relation that is (at
least in part) causal seems likely.
Additional morbidity and mortality following the de-
velopment of AF in patients with sepsis may be ex-
plained by the decrease in cardiac output and blood
pressure that occurs in most patients due to reduced left
ventricular filling. This is particularly the case in the
presence of rapid ventricular response rates. The result-
ing hemodynamic compromise may impair the recovery
of organ function in patients with severe sepsis or shock.
Furthermore, AF has been associated with the develop-
ment of intracardiac thrombi, posing a subsequent risk
of systemic embolization and stroke [30]. Harm, how-
ever, may also result from the indiscriminate use of anti-
coagulants in patients with AF, particularly in an ICU
setting. Unfortunately, there are presently no evidence-
based guidelines for the use of anticoagulant prophylaxis
in these patients [10,31].
Taken together, the management of new-onset AF in
critically ill patients with sepsis poses a major clinical
challenge. It may therefore be desirable to start phar-
macological prophylaxis in an attempt to prevent this
complication rather than to be reactive, provided that it
is possible to adequately identify patients who are at
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study investigating the effect of esmolol in patients with
septic shock gives support to the feasibility of such
approach [32]. Although reducing heart rate is likely to
improve cardiovascular function, treating sinus tachy-
cardia - and thereby possibly preventing AF - in patients
with sepsis remains controversial, however, and further re-
search is necessary before any recommendations regar-
ding pharmacological prophylaxis can be made.
Our review is the first to give a systematic overview of
the reported incidences, risk factors and outcomes asso-
ciated with AF during sepsis in the ICU. However, our
review has several limitations, primarily because the ma-
jority of the included papers pertained to single center
studies with small sample sizes, whereas the few multicen-
ter studies that were included had retrospective designs
and used only administrative data (such as ICD-9-CM
codes) for the classification of both sepsis and new-onset
AF. In addition, many studies did not discriminate bet-
ween the various sepsis stages when reporting the occur-
rence of new-onset AF [16,17,19,22,23,26]. Furthermore,
there was large statistical heterogeneity as well as varia-
bility in clinical settings amongst studies. This precluded
pooling of data into a meta-analysis. At last, it still remains
uncertain whether new-onset AF in patients with sepsis is
merely a marker for severity of disease, or whether it truly
impacts outcome. Therefore further research is warranted
to demonstrate independent associations with morbidity
and mortality.
Conclusions
New-onset AF is a common occurrence in critically ill
patients with sepsis, and its incidence rises with increa-
sing severity of disease. Multivariable analyses suggest
that it is independently associated with poor outcome,
but whether this relation is truly causal remains difficult
to establish. In view of these findings there is a need for
better quality observational studies, because reliable
identification of patients with sepsis who are prone for
the development of AF may allow for early pharmaco-
logical interventions to prevent this complication.
Key messages
 New-onset AF is a common complication in
critically ill patients with sepsis and its incidence
increases with progression of the disease stage.
 New-onset AF is independently associated with a
risk of stroke, a prolonged length of stay in the ICU,
and increased mortality.
 Early identification of patients who are at increased
risk for developing AF seems feasible and may allow
for pharmacological interventions to prevent this
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